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A number of recent observations have suggested that the cndocyh and biosynthetic pathways may share fundamentally similar transport 
mechanisms atthe molecular level. Some of the more striking of these suggestions have come from a comparison of the erects of the mncrocyclic 
lactonc brefcldin A (BFA) on endosomcs and the Golgi complex. BFA is thought o affect Golgi-specific oat proteins that may be involved in 
maintaining the structural integrity of the organelle and in regulating membrane transport in the secretory pathway. Many o/’ the cffec’ecls of BFA 
on the cndocytic system. such as the guonine nuclco\ide and aluminum fluoride (AIFJ-regulated induction of microtubulc-depndent cndosomal 
tubules, arc strikingly reminiscent of the action of the drug on the Golgi complex, Therefore, the similar mcchonisms of action of the drug on 
cndosomcs suggest that organellcs of the endocytic pathway may be associated with similar cytoplasmic coats that could regulate ndosomc function 
and integrity. 
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1. EFFECTS OF BFA ON THE GOLGI COMPLEX 
Over the past few years, analysis of the action of the 
fungal antibiotic BFA on the Golgi complex has led to 
significant insights into the molecular mechanisms of 
membrane traffic in the secretory pathway. The first 
observed effects of DFA were the inhibition of protein 
secretion and the breakdown of the Golgi complex [l- 
43. Concomitant with disassembly, components of the 
Golgi complex are delivered to the ER via retrograde 
transport involving tubular extensions and facilitated 
by intact cytoplasmic microtubules [S]. These dramatic 
effects of BFA appear to reflect he immediate dissocia- 
tion of a non-clathrin-containing cytoplasmic oat from 
Golgi membranes [G--8]. The peripheral coat is assem- 
bled from cytoplasmic precursors and is believed to 
participate in the formation of Golgi-derived transport 
vesicles [9], and/or to play a role in regulating the forma- 
tion oftubules that may be involved in transport [lO,ll]. 
BFA induces the redistribution of at least three ccm- 
ponents of this coat material, &COP, ADP ribosylation 
factor (ARF) and y-adaptin, from Golgi membranes to 
the cytosol, most likely by interfering with their ability 
to bind to the Golgi [7,12,13]. Both @-COP and y- 
adaptin share significant homology to the p-subunit of 
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the clathrin adaptor complex of endocytic oated vesi- 
cles [6,8], already suggesting similarities in the transport 
mechanisms of the two pathways. Binding of ,&COP, 
y-adaptin and ARF (a low molecular weight GTP bind- 
ing protein [ 143) are directly or indirectly regulated by 
guanine nucleotides since pretreatment of cells or Golgi 
membranes with AIF$ or GTPyS inhibits the action of 
BFA [12]. Sequential addition experiments of /3-COP 
and ARF suggest hat ARF-binding is required for as- 
sociation of B-COP with Golgi membranes. Although 
GTPyS promotes membrane-association f both @- 
COP and ARF, only /?-COP binding is enhanced by 
AIF;. This differential effect of AlF; has been taken to 
imply a role of trimeric G proteins in regulating mem- 
brane assembly of BFA sensitive coat proteins, in par- 
ticular because AlF; is thought o specifically target he 
trimeric G proteins without affecting the low molecular 
weight GTP binding proteins of which ARF is a mem- 
ber [14,15]. Such an involvement of trimeric G proteins 
has mere directly been shown by the inhibitory effect of 
purified By subunits of G proteins on AIF; and GTPyS- 
induced binding of ARF and /I-COP to Golgi mem- 
branes [12]. More recently, the trimeric G protein-acti- 
vating peptide mastoparan has been shown to promote 
binding of /%COP to Golgi membranes and to antago- 
nize the effect of BFA [16]. Since pre-treatment of the 
cells with pertussis toxin abolished the ability of masto- 
paran to inhibit the action of BFA, it is likely that 
activation of a pertussis toxin-sensitive Gss regulates 
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binding of ARF and /3-COP to the cytoplasmic face of 
the Golgi complex. 
2. EFFECTS OF BFA ON ENDOCYTIC ORGAN- 
ELLES AND MEMBRANE TRAFFIC 
Whilst not previously thought to affect any intracel- 
lular organelle other than the Golgi, it has recently be- 
come clear that BFA can also target several endocytic 
organellcs in a fashion reminescent of its action on the 
Golgi complex. BFA has been found to significantly 
increase the tubular appearance of the early endosomal 
compartment involved in recycling of internalized 
transferrin receptors. As visualized by EM, BFA-in- 
duced endosomal tubules display a diameter of * 100 nm 
and appear to emanate from the centriole region. As is 
the case for Golgi-tubules, the BFA-induced endosomal 
tubular network is stabilized by cytoplasmic microtu- 
bules and is not observed in the presence of AIF; [I?- 
193. 
The dramatic morphological changes induced by 
BFA do not, however, appreciably alter internalization 
to and recycling from endosomes [17,18]. At least in 
some cells, however, BFA appears to induce the fusion 
of the trans-Golgi network (TGN) with the plasma 
membrane and/or the early endosomal compartment 
[IS, 191. As a result, TGN proteins were found to be 
delivered to the cell surface from where they were inter- 
nalized and recycled through a compartment involved 
in internalization and recycling of transferrin. 
Although BFA has been found to exhibit profound 
morphological effects on endocytic organelles, the drug 
does not markedly affect internalization, recycling, or 
delivery of internalized ligands from early endosomes to 
degradative ndocytic ompartments [17,18]. However, 
since degradation i  the presence of the drug could also 
occur in late endosomes which are known to contain 
degradative nzymes, it remains unclear whether the 
drug affects transport from cndosomes to lysosomes. 
Although the morphology of late endosomes was not 
altered by the presence of BFA, lysosomes acquired a 
more tubular appearance [I81, 
The morpholrrgical effects of BFA on endocytic or- 
ganelles were even observed in two cell lines, MDCK 
and PtKl, where high BFA concentrations failed to 
have an effect on the Golgi complex as evidenced in the 
persistence ofcharacteristic B-COP-coated Golgi stacks 
[ 17,18,20]. Although MDCK and PtK I cells are derived 
from kidney of dog and rat kangaroo, respectively, the 
resistance ofthese cells to BFA does not reflect an insen- 
sitivity of kidney cells, or epithelial cells in general, since 
the Golgi of a porcine kidney cell line, LLC-PK, is 
sensitive to the drug (unpublished results). Whether re- 
sistance of the Golgi to BFA is a species-specific feature, 
or a more widespread phenomenon, remains to be de- 
termined. This restricted effect of the drug on en- 
dosomes but not on the Golgi suggests, however, that 
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the mechanism of the effect of the drug on the two 
pathways may be similar but certainly not identical. 
Thus, while BFA elicits dramatic and widespread 
morphological alterations to endosomes and lysosomes 
in diverse cells, it is apparent hat these organelles re- 
main largely functional with endocytosis, recycling and 
delivery to degradative compartments continuing una- 
bated. We have found, however, that the drug selec- 
tively and completely blocks one type of endocytic 
transport event, namely basolateral to apical transcyto- 
sis of dIgA mediated by the polymeric immunoglobulin 
receptor (pIgR) in polarized MDCK cells [17]. 
As found for transferrin, BFA did not affect internal- 
izaton or recycling via the pIgR in transfected MDCK 
cells. Transcytosis of receptor-bound dimeric IgA, how- 
ever, was almost completely blocked [see Fig. 1). The 
drug appears to target an early step in the pathway since 
maximum inhibition is only obtained within S-10 min 
after internalization. Furthermore. it is likely that the 
drug affects transcytosis at a step prior to the microtu- 
bule-dependent translocation of transcytotic vesicles 
from the basolateral to the apical cytoplasm since incu- 
bation of dIgA bound to pIgR in the presence of the 
microtubule-disrupting drug nocodazole allows trans- 
port beyond the BFA-sensitive step of the pathway. 
Indeed, preliminary results uggest hat dIgA and trans- 
ferrin bound to their respective receptors are prevented 
from segregating in the presence of BFA (W. Hunziker 
et al., unpublished results). These observations there- 
fore strongly suggest hat either sorting of plgR-dIgA 
into transcytotic vesicles, and/or the formation of trans- 
cytotic vesicles might be affected by BFA. 
Intriguingly, despite the inhibitory effect on dIgA 
transcytosis, BFA has also been reported to increase the 
transcellular delivery of several normally non-transcy- 
tosed proteins [2 l]. These apparently contradictory 
findings suggest hat transcytosis of membrane might 
still occur in the presence of BFA, but that the efficient 
sorting of transcytotic proteins such as the plgR from 
early endosomes into transcytotic arriers might specif- 
ically be affected. Alternatively, more than one transcy- 
totic pathway might exist and in the presence of BFA 
transport from basolateral early endosomes across the 
cell to the apical surface could possibly take place via 
late endosomes. 
3. IMPLICATIONS ON ENDOCYTIC TRANS- 
PORT AND SORTING MECHANISMS 
BFA has been found to display striking similarities in 
its action on the exocytic and endocytic pathways, 
strongly suggesting fundamental similarities in the bio- 
chemical basis of membrane traffic in the two pathways. 
Most notably, the morphological integrity of organelles 
in both pathways is severely affected by the drug. This 
morphological effect is dependent on intact cytoplasmic 
microtubules and appears to be regulated by GTPyS 
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Fig. I. BFA blocks trunscytosis but not internalization or recycling of plgR. 1251.dlgA w&i prebound on ice from the basolateral surface of 
transfccted MDCK cells. Cells wcrc then transferred to 37°C in the presence or absence of BFA. dIgA tnnscytosed (rclcaserl into the apical medium 
and present on the apical surface; panel A), present on the basolateral surkcc (acid sensitive; panel B), intracellular (acid resistant: panel C) or 
released into the basolateral medium (panel D) was determined at the indicated periods of time and plotted as % of initially bound d&A. Points 
were determined in duplicate and%-values differed by less than 15%. 
and AIFi in a similar way in both pathways. Since the 
morphological changes induced by BFA on the Golgi 
complex appear to directly reflect the association of a 
distinct non-clathrin coat, it is tempting to assume that 
the drug likewise targets a similar cytoplasmic oat as- 
sociated with endocytic organelles. As is the case in the 
Golgi, such a BFA-sensitive coat could play a role in 
endosome function and in regulating organelle integrity 
by preventing tubule formation and homotypic fusion 
among related structures. In contrast o several BFA- 
sensitive coat proteins idemified su far on Golgi mem- 
branes, however, none of the cytoplasmic proteins 
known to interact with the cytoplasmic face of en- 
dosomes are sensitive to BFA. Association of proteins 
of the rab family with early (rab 4 and rab 5) or late (rab 
7) endosomes is not affected by the drug (I?. van der 
Sluijs, personal communication). Similarly, the a-sub- 
unit of the HA2 adaptor complex of the clathrin coat 
of early crldocytic pits and vesicles is not targettcd by 
the drug [13], even though the y-subunit of the HA1 
adaptor complex of the TGN clathrin coat is a target 
of BFA, 
Of particular interest is the selective ffect of BFA on 
pIgR-mediated basolateral to apical transcytosis, and 
several possible mechanisms can be postulated and ex- 
perimentally tested (see Fig. 2). Conceivably, the recog 
nition and sorting event that leads to sc-questration f 
p&R from basolatcrnl early endosomes into transcy- 
totic vesicles may involve an interaction with a /3- 
adaptin@COP-like endosomal coat protein. Alterna- 
tively, cytoplasmic oat proteins required for transcy- 
totic carrier formation and/or function, such as the 108 
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Fig. 2. BFA and sorting in basolateral early endosomes. Shown are 
the thrcr possible fntes of membrane proteins following endocylosis 
form the basolaural surface: recycling back to the surface of intcrnal- 
ization, delivery to late cndosomes and lysosomes, and transport 
across the cell to the opposite surface. BFA selectively affects transcy- 
tosis, suggesting that the drug might target a putative coat on cndo- 
cytic organelles. Such a coat could be required for the segregation of
a restricted set of proteins into transcytotic vesicles, or for the forma- 
tion and/or function of transcytotic arriers. 
kDa protein specific for transcytotic vesicles [22], may 
be affected by BFA. 
Over the past few years a number of low molecular 
GTP-binding proteins of the rab family have been im- 
plicated in functions of the endocytic pathway such as 
early endosome fusion [23]. It has recently become clear 
that, perhaps not unexpected from their role in regulat- 
ing coat binding and membrane transport in the ex- 
ocytic pathway [24], hcterotrimeric G proteins may also 
play a role during different steps in endocytosis. The 
trimeric G protein activating peptide mastoparan was 
found to inhibit early endosome fusion [25]. In addition, 
the stimulatory effect of GTPyS on fusion was found to 
be antagonized by j3y subunits of G proteins. Heterotri- 
merit G proteins are probably also involved in trans- 
cytosis, a pathway also reportedly affected by AIF; in 
a psrmeabilized cell system [26]. Whether G proteins 
also regulate binding of coat proteins to endocytic or- 
ganelles, however, remains to be determined. 
In conclusion, the similar effects of BFA and the 
involvement of trimeric G proteins in the function of the 
Golgi and endocytic orpanelles uggest hat the molec- 
ular mechanisms of membrane transport in the exocytic 
and endocytic pathway may be fundamentally similar. 
Clearly, the identification and characterization of puta- 
tive coat proteins on endocytic orpanelles will be critical 
for a more detailed understanding of the biochemical 
basis of membrane transport and sorting during endo- 
cytosis. 
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